Sort
82,697 grants matching “vaccine development”
Factors Influencing Oral Transmission of SIV
$737,560Donald L Sodora · Seattle Biomedical Research Institute · R01 · FY2009 · DE
Adoptive MHC-E-Restricted T Cell Therapy for the Treatment of Chronic Hepatitis B Virus Infection
$737,535Benjamin J Burwitz · Oregon Health & Science University · R01 · FY2021 · AI
Single-Cell Analysis of Transcriptional and Epigenetic Landscape in Immune Cells
$737,515William Nicholas Haining · Emory University · U19 · FY2017 · AI
Translational Use of Intradermal Needle-free Injector to facilitate and optimize global fractional dose HPV vaccine administration
$737,511Erin Kathleen Spiegel · Pharmajet, Inc. · R44 · FY2022 · CA
Correlates of protective immunity to HCV and rational vaccine design: Project 2
$737,505Arash Grakoui · Emory University · U19 · FY2021 · AI
Development of a novel quadrivalent seasonal influenza vaccine using E.coli production technology
$737,500Shengqiang Li · Sciogen, Llc · R44 · FY2016 · AI
Small Molecule Inhibitors of Ebola Virus Infection
$737,484James M Cunningham · Harvard Medical School · U19 · FY2017 · AI
Pathogenic Determinants of SIV Envelope Glycoproteins
$737,476University Of Pennsylvania · R01 · FY2001 · AI
Preclinical-Clinical Paramyxovirus Vaccine Development
$737,453St. Jude Children'S Research Hospital · P01 · FY2004 · AI
Aberrant immune activation in the tuberculosis granuloma: a pivotal role in necrosis
$737,411Igor Kramnik · Boston University Medical Campus · R01 · FY2017 · HL
Immune Responses To HIV And Other Pathogens
$737,356Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Ultrasensitive detection of Mycobacterium tuberculosis infection
$737,342Jeffrey D. Cirillo · Texas A&M University Health Science Ctr · R01 · FY2024 · AI
Optimization of novel phenotypic screening hits for treatment of Malaria
$737,236Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2023 · AI
Optimization of novel phenotypic screening hits for treatment of Malaria
$737,236Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2022 · AI
Optimization of novel phenotypic screening hits for treatment of Malaria
$737,236Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2024 · AI
Infant immune mechanisms of HIV reservoir size and decay
$737,227Grace C John-Stewart · University Of Washington · R01 · FY2019 · HD
Antibody Landscape following Human Norovirus Infection and Vaccination
$737,210Ralph S Baric · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AI
Proteomics-Driven Reverse Vaccinology for Gonorrhea
$737,096Aleksandra Elzbieta Sikora · Oregon State University · R01 · FY2024 · AI
Modeling toolkit to evaluate multifaceted control strategies for seasonal and pandemic influenza
$737,051Lauren Ancel Meyers · University Of Texas At Austin · U01 · FY2021 · IP
The Lymphoid Tissue Pharmacology of Antiretroviral Drugs
$737,007Courtney V. Fletcher · University Of Nebraska Medical Center · R01 · FY2019 · AI
Trypanosome flagellum structure, assembly, and mechanism
$736,920Kent L Hill · University Of California Los Angeles · R01 · FY2025 · AI
Pre-Clinical Immunogenicity Testing of Chimp Adenovirus Vectors
$736,884Hildegund C. J. Ertl · Wistar Institute · U19 · FY2008 · AI
Design of fusion inhibitors to block measles host-to-host infection
$736,876Matteo Porotto · Columbia University Health Sciences · R01 · FY2023 · AI
Longitudinal Immunological Impact of SARS-CoV-2 Infection
$736,876Timothy Jensen Henrich · University Of California, San Francisco · R01 · FY2021 · AI
REDES: a peer network and mobile health (mHealth) enhanced CHW model to maximize COVID-19 vaccination among low income Latinos
$736,867Kathleen R Page · Johns Hopkins University · R01 · FY2025 · MD